Skip to content
  • Home
  • About
  • Aims & Scope
  • Editorial Board
  • Advisory Board
  • News
  • Notices
  • Contact
  • facebook
  • instagram
The Journal of Diagnostic and Theranostic Imaging [TheJODTi]

The Journal of Diagnostic and Theranostic Imaging [TheJODTi]

"Open Access & Peer Review & Innovation & Scientific Impact" e-ISSN: 3108-3676

  • Current Issue
    • Table of Contents
    • Current Issue
  • Articles in Press
  • All Issues
  • Guide for Authors
    • Instructions For Authors
    • Forms of Paper Submission
    • The Peer Review Process
    • Abstracting & Indexing
    • Journal Metrics
    • Useful Links for Authors
  • Guide for Reviewers
    • Becoming a reviewer
    • Guide for Reviewers
  • Toggle search form

Frequently Asked Questions

Frequently Asked Questions | The JODTi

Frequently Asked Questions

Will my manuscript be reviewed within a specific timeframe?
Yes, absolutely! We aim to complete the initial review process within 2–3 weeks from the date of submission. This ensures you receive timely feedback while maintaining the integrity of our peer-review process.
Is there a fee for manuscript submission or publication?
No, The Journal of Diagnostic and Theranostic Imaging (TheJODTi) is committed to supporting researchers. There are no submission or publication fees, and all published articles are freely accessible under our open-access policy.
What types of manuscripts does the journal accept?
We accept a variety of submissions, including:
  • Original Research Articles
  • Review Articles
  • Short Communications
  • Case Reports
  • Letters to the Editor
For more details on manuscript requirements, visit our Instructions for Authors.
Are all published articles freely accessible?
Yes, all articles are available free of charge under our open-access policy. This ensures maximum visibility and accessibility for your work worldwide.
How do I check the status of my submitted manuscript?
You can log in to our online submission system to track the progress of your manuscript. If you have specific questions, feel free to contact our editorial office at editor@thejodti.org.
Are there formatting requirements for submissions?
Yes, manuscripts should adhere to the formatting guidelines outlined in our Instructions for Authors. These include structured abstracts, AMA-style references, and proper formatting for figures and tables.
Can I submit a case report?
Yes, Case Reports are welcome, provided they offer novel insights or unique clinical findings relevant to diagnostic imaging and theranostics.
How do I become a reviewer for the journal?
We welcome experts in diagnostic imaging and theranostics to join our reviewer pool. You can express your interest by emailing your CV and areas of expertise to editor@thejodti.org.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Telegram (Opens in new window) Telegram
  • Share on Reddit (Opens in new window) Reddit
  • Share on Threads (Opens in new window) Threads
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
  • Official Announcement: The Journal of Diagnostic and Theranostic Imaging (TheJODTi) Now Assigns DOIs TheJODTi
  • FDG-Avid Non-Ossifying Fibromas Mimicking Metastases in Pediatric Ewing Sarcoma: A Diagnostic Pitfall on PET/CT TheJODTi
  • Exciting News! THEJODTi is now proudly indexed in the OUCI Announcement
  • Our Focus Areas TheJODTi
  • Radiological Features of Giant Pelvic Chondrosarcoma TheJODTi
  • The Peer Review Process TheJODTi
  • Improved Detection of Brain Metastases on Delayed FDG PET/CT Imaging in Lung Cancer TheJODTi
  • Welcome to The Journal of Diagnostic and Theranostic Imaging (TheJODTi) Announcement
  • Detection and Implications of Increased PSMA Uptake in Thyroid Nodule Following Lu-177 PSMA Therapy: A Case of Hürthle Cell Variant Thyroid Papillary Carcinoma Identified by Ga-68 PSMA PET/CT TheJODTi
  • Our Vision TheJODTi
  • Gluteal Muscle Metastasis from Squamous Cell Carcinoma of the Lung: A Case Report TheJODTi
  • Rare Solitary Brain Metastasis from Colon Cancer Spotted by PET/CT Leads to Lifesaving Multimodal Therapy News
  • The Journal of Diagnostic and Therapeutic Imaging (TheJODTi) is Now Officially Indexed in Crossref! Announcement
  • Uncommon Finding: Occipital Spur on Tc-99m PYP Scintigraphy in Cardiac Amyloidosis TheJODTi
  • Predictive Values of [18F]FDG PET/CT Metabolic Parameters In The Occurrence of Metastasis In Patients Diagnosed With Triple-Negative Breast Cancer TheJODTi
HomeHome21 Jun 2025
All IssuesAll Issues19 Jun 2025
Rare Discordance Between 68Ga-DOTATATE and 68Ga-PSMA PET/CT in a Metastatic Ileal Neuroendocrine Tumor: A Case Report and Literature ReviewRare Discordance Between 68Ga-DOTATATE and 68Ga-PSMA PET/CT in a Metastatic Ileal Neuroendocrine Tumor: A Case Report and Literature Review6 Jul 2025
FDG-Avid Non-Ossifying Fibromas Mimicking Metastases in Pediatric Ewing Sarcoma: A Diagnostic Pitfall on PET/CTFDG-Avid Non-Ossifying Fibromas Mimicking Metastases in Pediatric Ewing Sarcoma: A Diagnostic Pitfall on PET/CT6 Jul 2025
FDG-Avid Non-Ossifying Fibromas Mimicking Metastases in Pediatric Ewing Sarcoma: A Diagnostic Pitfall on PET/CTFDG-Avid Non-Ossifying Fibromas Mimicking Metastases in Pediatric Ewing Sarcoma: A Diagnostic Pitfall on PET/CT27 Jun 2025
Our VisionOur Vision23 Nov 2024
Complete 68Ga-DOTATATE/PSMA PET/CT Discordance Documented in Metastatic Ileal Neuroendocrine TumorComplete 68Ga-DOTATATE/PSMA PET/CT Discordance Documented in Metastatic Ileal Neuroendocrine Tumor30 Jun 2025
Rare Solitary Brain Metastasis from Colon Cancer Spotted by PET/CT Leads to Lifesaving Multimodal TherapyRare Solitary Brain Metastasis from Colon Cancer Spotted by PET/CT Leads to Lifesaving Multimodal Therapy30 Jun 2025
Becoming a reviewerBecoming a reviewer28 Nov 2024

Copyright © 2025 The Journal of Diagnostic and Theranostic Imaging [TheJODTi]. e-ISSN: 3108-3676. Privacy Policy

Powered by PressBook News WordPress theme

Loading Comments...